Related Experiment Video
Updated: Mar 8, 2026
09:30
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.6K
Systemic Market and Organizational Changes: Impact on P&T Committees
P & T : a Peer-Reviewed Journal for Formulary Management
|January 17, 2017
Summary
Future pharmacy and therapeutics (P&T) committees will face market consolidation, efficiency demands, and patient rights. These factors will shape how P&T committees approach drug access and formulary decisions.
Area of Science:
- Health Policy
- Pharmaceutical Economics
- Clinical Pharmacy Practice
Background:
- Increasing market stakeholder consolidation impacts pharmaceutical supply chains and decision-making.
- Market-driven efficiency demands are reshaping healthcare resource allocation.
- Growing consumerism and legal enforcement of patient rights influence drug accessibility.
Purpose of the Study:
- To analyze the evolving landscape influencing pharmacy and therapeutics (P&T) committees.
- To anticipate future challenges and strategic approaches for P&T committees.
- To examine the interplay of market forces, patient rights, and drug access.
Main Methods:
- Review of current trends in market consolidation and healthcare economics.
- Analysis of legal frameworks concerning patient rights and drug access.
- Synthesis of stakeholder perspectives on P&T committee functions.
Main Results:
- P&T committees will need to navigate complex market dynamics and regulatory pressures.
- Balancing cost-effectiveness with patient access to appropriate medications is a key challenge.
- Proactive adaptation to legal and consumer demands will be crucial for committee effectiveness.
Conclusions:
- Future P&T committees must adopt strategic frameworks to address market consolidation and efficiency demands.
- Ensuring equitable patient access to necessary medications requires adapting to legal and consumerism trends.
- P&T committees play a vital role in optimizing drug utilization within evolving healthcare markets.
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
629
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
629
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
58
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
58
01:26FDA Approved Drugs: Changes to Approved Drugs
302
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
302
01:28Drug Products: Biologics, Biosimilars and Interchangeables
328
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
328
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
77
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
77
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K